Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

GSK-3

GSK3 (glycogen synthase kinase-3) is a serine/threonine protein kinase which contributes to cell survival, diabetes, insulin resistance and Alzheimer's diseases.

Items 1-10 of 21

Page
per page
  1. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  2. AR-A014418
    A3184 AR-A014418
     2 Citation
    Target: GSK-3
    Summary: GSK3β inhibitor, ATP-competitive and selective
      insoluble in EtOH; insoluble in H2O; ≥15.4 mg/mL
  3. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  4. SB 216763
    A8240 SB 216763
     3 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor,ATP-competitive,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥56.8 mg/mL
  5. SB 415286
    A8241 SB 415286
     1 Citation
    Summary: GSK-3 inhibitor,potent and selective
      insoluble in H2O; ≥18 mg/mL
  6. CHIR-98014
    A8395 CHIR-98014
    Target: GSK-3
    Summary: GSK-3β inhibitor,selective and ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥8.1 mg/mL
  7. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  8. TWS119
    B1540 TWS119
     1 Citation
    Summary: GSK-3β inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.9 mg/mL
  9. TDZD-8
    B1249 TDZD-8
     1 Citation
    Summary: GSK-3β inhibitor
      insoluble in H2O; ≥11.1 mg/mL
  10. TCS 2002
    B5486 TCS 2002
    Summary: GSK -3β inhibitor, potent
      <33.84 mg/mL

Items 1-10 of 21

Page
per page